标题
A guide to immunotherapy for COVID-19
作者
关键词
-
出版物
NATURE MEDICINE
Volume 28, Issue 1, Pages 39-50
出版商
Springer Science and Business Media LLC
发表日期
2022-01-22
DOI
10.1038/s41591-021-01643-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial
- (2021) Eli Mansour et al. Trials
- Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis
- (2021) Lee S. Nguyen et al. INTENSIVE CARE MEDICINE
- Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children
- (2021) Naïm Ouldali et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19
- (2021) Nico A F Janssen et al. JOURNAL OF INFECTIOUS DISEASES
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study
- (2021) Nuria Muñoz-Rivas et al. THROMBOSIS RESEARCH
- Deciphering the state of immune silence in fatal COVID-19 patients
- (2021) Pierre Bost et al. Nature Communications
- Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
- (2021) Chaja F. Jacobs et al. Blood Advances
- Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
- (2021) Stefanie Kreutmair et al. IMMUNITY
- Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
- (2021) Azita H. Talasaz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent
- (2021) Aliye Bastug et al. RHEUMATOLOGY INTERNATIONAL
- Clinical features and prognostic factors in Covid-19: A prospective cohort study
- (2021) Sanne de Bruin et al. EBioMedicine
- Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
- (2021) Roberto Caricchio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
- (2021) Renato D Lopes et al. LANCET
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Multisystem Inflammatory Syndrome in Children
- (2021) Andrew J. McArdle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Use of convalescent plasma in COVID ‐19 patients with immunosuppression
- (2021) Jonathon W. Senefeld et al. TRANSFUSION
- Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
- (2020) Luca Richeldi et al. BMC Pulmonary Medicine
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
- (2020) Frank L van de Veerdonk et al. eLife
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
- (2020) Piero Ruscitti et al. Frontiers in Immunology
- Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
- (2020) Marie Pouletty et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
- (2020) Elizabeth Whittaker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
- (2020) Eva W. Cheung et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multisystem Inflammatory Syndrome in Children (MIS‐C) Related to COVID‐19: A New York City Experience
- (2020) Mariawy Riollano‐Cruz et al. JOURNAL OF MEDICAL VIROLOGY
- Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
- (2020) Leora R. Feldstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital
- (2020) Tristan Ramcharan et al. PEDIATRIC CARDIOLOGY
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
- (2020) Julie Toubiana et al. BMJ-British Medical Journal
- American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1
- (2020) Lauren A. Henderson et al. Arthritis & Rheumatology
- Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
- (2020) Pierre Francois Laterre et al. JAMA Network Open
- Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
- (2020) Frank L. van de Veerdonk et al. JAMA Network Open
- Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
- (2020) Ian Huang et al. Journal of Intensive Care
- Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management
- (2020) Natasha A. Nakra et al. Children-Basel
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children
- (2020) Pui Y. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
- (2020) Tariq U. Azam et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
- (2020) Didier Payen et al. Frontiers in Immunology
- A narrative review of venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
- (2020) Andrea T. Obi et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020
- (2020) Sapna Bamrah Morris et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention
- (2019) Anna Aiello et al. Frontiers in Immunology
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- C5a and TNF- Up-Regulate the Expression of Tissue Factor in Intra-Alveolar Neutrophils of Patients with the Acute Respiratory Distress Syndrome
- (2014) K. Kambas et al. JOURNAL OF IMMUNOLOGY
- Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
- (2013) Kendra N. Iskander et al. PHYSIOLOGICAL REVIEWS
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies
- (2009) S. V. Seshan et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More